Liping Yu Selected Research

insulin B (9-23)

1/2020	A monoclonal antibody with broad specificity for the ligands of insulin B:9-23 reactive T cells prevents spontaneous type 1 diabetes in mice.
7/2008	Conserved T cell receptor alpha-chain induces insulin autoantibodies.
7/2006	Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout.
6/2004	Genetic differentiation of poly I:C from B:9-23 peptide induced experimental autoimmune diabetes.
11/2003	Nondepleting anti-CD4 monoclonal antibody prevents diabetes and blocks induction of insulin autoantibodies following insulin peptide B:9-23 immunization in the NOD mouse.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liping Yu Research Topics

Disease

103	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 01/2002
18	Neoplasms (Cancer) 01/2022 - 04/2006
13	Celiac Disease (Celiac Sprue) 01/2022 - 09/2003
12	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2002
10	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2008
10	Insulinoma 05/2021 - 03/2005
8	Inflammation (Inflammations) 08/2021 - 12/2008
8	Cardiomegaly (Heart Hypertrophy) 06/2018 - 02/2010
8	Addison Disease (Addison's Disease) 10/2015 - 01/2005
7	Thyroid Diseases (Thyroid Disease) 05/2021 - 04/2005
7	Hypertrophy 02/2017 - 02/2010
6	Myocardial Infarction 12/2021 - 02/2016
6	Heart Failure 08/2021 - 07/2011
6	Glioma (Gliomas) 10/2017 - 12/2010
5	Hypertension (High Blood Pressure) 01/2021 - 10/2013
5	Disease Progression 01/2019 - 11/2003
4	Fibrosis (Cirrhosis) 08/2021 - 10/2013
4	Obesity 01/2021 - 01/2007
4	Infections 01/2021 - 07/2011
4	Body Weight (Weight, Body) 01/2021 - 05/2010
4	Hyperglycemia 01/2020 - 01/2007
4	Diabetes Mellitus 01/2020 - 10/2013
4	Essential Hypertension 04/2018 - 02/2010
4	Muscular Dystrophies (Muscular Dystrophy) 10/2016 - 01/2010
3	Tic Disorders (Tic Disorder) 05/2022 - 01/2020
3	Stroke (Strokes) 01/2022 - 07/2016
3	Pneumonia (Pneumonitis) 01/2022 - 04/2020
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2019
3	Infarction (Infarctions) 12/2021 - 02/2016
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 06/2014
3	Blindness (Hysterical Blindness) 10/2019 - 01/2017
3	Leber Congenital Amaurosis 01/2019 - 01/2017
3	Anaphylaxis (Anaphylactic Shock) 01/2004 - 10/2002
2	Lung Neoplasms (Lung Cancer) 05/2022 - 04/2010
2	Fever (Fevers) 10/2021 - 02/2002
2	Abdominal Pain (Pain, Abdominal) 10/2021 - 02/2002
2	Myasthenia Gravis 10/2021 - 10/2021
2	Thyroiditis 05/2021 - 09/2011
2	Insulin Resistance 01/2021 - 01/2013
2	COVID-19 01/2021 - 10/2020
2	Autistic Disorder (Autism) 01/2021 - 02/2015
2	Carcinogenesis 01/2021 - 01/2021
2	Carcinoma (Carcinomatosis) 08/2020 - 03/2017
2	Cardiovascular Abnormalities 07/2020 - 09/2012
2	Hyperlipidemias (Hyperlipidemia) 01/2020 - 07/2016

Drug/Important Bio-Agent (IBA)

75	AutoantibodiesIBA 01/2022 - 01/2002
45	Insulin (Novolin)FDA Link 01/2022 - 04/2002
21	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2002
15	Peptides (Polypeptides)IBA 01/2021 - 05/2002
14	AntibodiesIBA 01/2022 - 03/2002
14	AntigensIBA 05/2021 - 01/2005
12	AutoantigensIBA 04/2017 - 01/2002
9	EpitopesIBA 01/2020 - 01/2002
9	ResveratrolIBA 02/2017 - 02/2010
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2003
8	Class 8 Receptor-Like Protein Tyrosine PhosphatasesIBA 04/2017 - 03/2002
8	Steroid 21-Hydroxylase (21 Hydroxylase)IBA 10/2015 - 01/2005
7	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 05/2021 - 01/2010
6	Zinc Transporter 8IBA 05/2021 - 05/2011
6	ProinsulinIBA 01/2021 - 03/2005
5	TransglutaminasesIBA 01/2022 - 09/2003
5	C-PeptideIBA 01/2021 - 03/2005
5	insulin B (9-23)IBA 01/2020 - 11/2003
5	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2020 - 04/2005
5	PolyphenolsIBA 02/2017 - 05/2010
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 08/2004
4	Iodide Peroxidase (Deiodinase)IBA 05/2021 - 04/2005
4	Monoclonal AntibodiesIBA 01/2020 - 01/2013
4	LigandsIBA 01/2020 - 04/2006
4	ZincIBA 01/2020 - 06/2011
4	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2011 - 01/2002
3	AntioxidantsIBA 10/2021 - 12/2014
3	Therapeutic UsesIBA 11/2020 - 12/2014
3	Antihypertensive Agents (Antihypertensives)IBA 07/2020 - 07/2016
3	CytokinesIBA 04/2020 - 04/2012
3	HLA-DR Antigens (HLA-DR)IBA 01/2020 - 09/2006
3	Amino Acids FDA Link 01/2020 - 10/2002
3	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2019 - 07/2015
3	Dystroglycans (Dystroglycan)IBA 10/2016 - 08/2013
3	MicroRNAs (MicroRNA)IBA 01/2014 - 07/2011
3	Tyrosine (L-Tyrosine)FDA Link 06/2005 - 01/2002
2	tyramine-deoxysorbitolIBA 05/2022 - 01/2020
2	CholesterolIBA 12/2021 - 01/2013
2	Hemoglobins (Hemoglobin)IBA 10/2021 - 01/2021
2	Thyroglobulin FDA Link 05/2021 - 04/2005
2	mitoquinoneIBA 01/2021 - 12/2014
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 02/2016
2	LipidsIBA 01/2021 - 01/2017
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 01/2013
2	Streptozocin (Streptozotocin)FDA Link 01/2021 - 10/2016
2	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 03/2017
2	Interferon-alpha (Interferon Alfa)IBA 01/2020 - 05/2004
2	Glutamic Acid (Glutamate)FDA Link 01/2020 - 01/2007
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2012
2	Superoxides (Superoxide)IBA 01/2020 - 10/2013

Therapy/Procedure

16	Therapeutics 08/2021 - 05/2002
5	Immunotherapy 01/2021 - 11/2003
2	Palliative Care (Palliative Therapy) 05/2022 - 01/2022
2	Thymectomy 10/2021 - 10/2021